Suppr超能文献

顺铂处理诱导鳞状癌细胞中磷酸化ΔNp63α/miRNA 反馈调节

Phospho-ΔNp63α/microRNA feedback regulation in squamous carcinoma cells upon cisplatin exposure.

机构信息

Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

出版信息

Cell Cycle. 2013 Feb 15;12(4):684-97. doi: 10.4161/cc.23598. Epub 2013 Jan 23.

Abstract

Our previous reports showed that the cisplatin exposure induced the ATM-dependent phosphorylation of ΔNp63a, which is subsequently involved in transcriptional regulation of gene promoters encoding mRNAs and microRNAs in squamous cell carcinoma (SCC) cells upon cisplatin-induced cell death. We showed that phosphorylated (p)-ΔNp63a plays a role in upregulation of pro-apoptotic proteins, while non-p-ΔNp63a is implicated in pro-survival signaling. In contrast to non-p-ΔNp63a, p-ΔNp63a modulated expression of specific microRNAs in SCC cells exposed to cisplatin. These microRNAs were shown to attenuate the expression of several proteins involved in cell death/survival, suggesting the critical role for p-ΔNp63a in regulation of tumor cell resistance to cisplatin. Here, we studied the function of ΔNp63a in transcriptional activation and repression of the specific microRNA promoters whose expression is affected by cisplatin treatment of SCC cells. We quantitatively studied chromatin-associated proteins bound to tumor protein (TP) p63-responsive element, we found that p-ΔNp63a along with certain transcription coactivators (e.g., CARM1, KAT2B, TFAP2A, etc.) necessary to induce gene promoters for microRNAs (630 and 885-3p) or with transcription corepressors (e.g., EZH2, CTBP1, HDACs, etc.) needed to repress promoters for microRNAs (181a-5p, 374a-5p and 519a-3p) in SCC cells exposed to cisplatin.

摘要

我们之前的报告表明,顺铂暴露诱导 ΔNp63a 的 ATM 依赖性磷酸化,随后涉及在顺铂诱导的细胞死亡中鳞状细胞癌 (SCC) 细胞中编码 mRNA 和 microRNA 的基因启动子的转录调节。我们表明,磷酸化的 (p)-ΔNp63a 在上调促凋亡蛋白中起作用,而非 p-ΔNp63a 参与促存活信号。与非 p-ΔNp63a 相反,p-ΔNp63a 调节暴露于顺铂的 SCC 细胞中特定 microRNA 的表达。这些 microRNAs 被证明可以减弱参与细胞死亡/存活的几种蛋白质的表达,表明 p-ΔNp63a 在调节肿瘤细胞对顺铂的耐药性方面具有关键作用。在这里,我们研究了 ΔNp63a 在顺铂处理 SCC 细胞后影响其表达的特定 microRNA 启动子的转录激活和抑制中的功能。我们定量研究了与肿瘤蛋白 (TP) p63 反应元件结合的染色质相关蛋白,发现 p-ΔNp63a 与某些转录共激活因子(例如,CARM1、KAT2B、TFAP2A 等)一起必需诱导 microRNA(630 和 885-3p)的基因启动子,或与转录核心抑制因子(例如,EZH2、CTBP1、HDACs 等)一起需要抑制 microRNA(181a-5p、374a-5p 和 519a-3p)的启动子在暴露于顺铂的 SCC 细胞中。

相似文献

1
Phospho-ΔNp63α/microRNA feedback regulation in squamous carcinoma cells upon cisplatin exposure.
Cell Cycle. 2013 Feb 15;12(4):684-97. doi: 10.4161/cc.23598. Epub 2013 Jan 23.
2
Phospho-ΔNp63α/SREBF1 protein interactions: bridging cell metabolism and cisplatin chemoresistance.
Cell Cycle. 2012 Oct 15;11(20):3810-27. doi: 10.4161/cc.22022. Epub 2012 Sep 5.
4
Phospho-ΔNp63α/microRNA network modulates epigenetic regulatory enzymes in squamous cell carcinomas.
Cell Cycle. 2014;13(5):749-61. doi: 10.4161/cc.27676. Epub 2014 Jan 6.
5
Phospho-ΔNp63α/miR-885-3p axis in tumor cell life and cell death upon cisplatin exposure.
Cell Cycle. 2011 Nov 15;10(22):3938-47. doi: 10.4161/cc.10.22.18107.
6
Phospho-ΔNp63α-responsive microRNAs contribute to the regulation of necroptosis in squamous cell carcinoma upon cisplatin exposure.
FEBS Lett. 2015 May 22;589(12):1352-8. doi: 10.1016/j.febslet.2015.04.020. Epub 2015 Apr 21.
7
Phospho-ΔNp63α is a key regulator of the cisplatin-induced microRNAome in cancer cells.
Cell Death Differ. 2011 Jul;18(7):1220-30. doi: 10.1038/cdd.2010.188. Epub 2011 Jan 28.
9
Phospho-ΔNp63α/Rpn13-dependent regulation of LKB1 degradation modulates autophagy in cancer cells.
Aging (Albany NY). 2010 Dec;2(12):959-68. doi: 10.18632/aging.100249.
10
Phospho-ΔNp63α regulates AQP3, ALOX12B, CASP14 and CLDN1 expression through transcription and microRNA modulation.
FEBS Lett. 2013 Nov 1;587(21):3581-6. doi: 10.1016/j.febslet.2013.09.023. Epub 2013 Sep 23.

引用本文的文献

1
Enhancer zeste homolog 2 (EZH2) targeting by small interfering RNA (siRNA); recent advances and prospect.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb 17. doi: 10.1007/s00210-025-03883-9.
2
How MicroRNAs Command the Battle against Cancer.
Int J Mol Sci. 2024 May 28;25(11):5865. doi: 10.3390/ijms25115865.
4
EZH2 Inhibition and Cisplatin as a Combination Anticancer Therapy: An Overview of Preclinical Studies.
Cancers (Basel). 2022 Sep 29;14(19):4761. doi: 10.3390/cancers14194761.
5
The p53 family reaches the final frontier: the variegated regulation of the dark matter of the genome by the p53 family in cancer.
RNA Biol. 2020 Nov;17(11):1636-1647. doi: 10.1080/15476286.2019.1710054. Epub 2020 Jan 7.
6
ΔNp63α Suppresses TGFB2 Expression and RHOA Activity to Drive Cell Proliferation in Squamous Cell Carcinomas.
Cell Rep. 2018 Sep 18;24(12):3224-3236. doi: 10.1016/j.celrep.2018.08.058.
7
Alleviation of Toxicity Caused by Overactivation of Pparα through Pparα-Inducible miR-181a2.
Mol Ther Nucleic Acids. 2017 Dec 15;9:195-206. doi: 10.1016/j.omtn.2017.09.008. Epub 2017 Sep 28.
8
Negative feedback between TAp63 and Mir-133b mediates colorectal cancer suppression.
Oncotarget. 2016 Dec 27;7(52):87147-87160. doi: 10.18632/oncotarget.13515.
9
The microRNA feedback regulation of p63 in cancer progression.
Oncotarget. 2015 Apr 20;6(11):8434-53. doi: 10.18632/oncotarget.3020.
10
p63 threonine phosphorylation signals the interaction with the WW domain of the E3 ligase Itch.
Cell Cycle. 2014;13(20):3207-17. doi: 10.4161/15384101.2014.951285.

本文引用的文献

1
Insights into p53 transcriptional function via genome-wide chromatin occupancy and gene expression analysis.
Cell Death Differ. 2012 Dec;19(12):1992-2002. doi: 10.1038/cdd.2012.89. Epub 2012 Jul 13.
3
Global tumor protein p53/p63 interactome: making a case for cisplatin chemoresistance.
Cell Cycle. 2012 Jun 15;11(12):2367-79. doi: 10.4161/cc.20863.
5
Is histone acetylation the most important physiological function for CBP and p300?
Aging (Albany NY). 2012 Apr;4(4):247-55. doi: 10.18632/aging.100453.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验